Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial

Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page now presents details of the SV-BR-1-GM and retifanlimab breast cancer trial, including its design, eligibility criteria, treatment arms, outcomes, locations, and record dates. The record indicates that the study is completed and no longer recruiting.
    Difference
    67%
    Check dated 2026-11-07T14:12:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:46:05.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:28:30.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-17T15:14:29.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number updates from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:17:06.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content with a generic error screen. The visible content and links to study details are no longer accessible on this page.
    Difference
    20%
    Check dated 2026-09-19T20:38:17.000Z thumbnail image

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.